Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
25,553,686
-
Shares change
-
+1,228,377
-
Total reported value, excl. options
-
$1,103,106,351
-
Value change
-
+$52,687,519
-
Put/Call ratio
-
3.08%
-
Number of buys
-
80
-
Number of sells
-
-75
-
Price
-
$43.15
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2014
195 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2014.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,553,686 shares
of 834,731,296 outstanding shares and own 3.06% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (3,773,114 shares), COMMONWEALTH BANK OF AUSTRALIA (2,350,051 shares), FIL Ltd (1,564,663 shares), BlackRock Group LTD (1,539,264 shares), VANGUARD GROUP INC (1,266,962 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1,048,196 shares), HANSBERGER GLOBAL INVESTORS INC/FL (867,997 shares), JPMORGAN CHASE & CO (665,372 shares), AQR CAPITAL MANAGEMENT LLC (538,245 shares), and Sectoral Asset Management Inc (509,917 shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.